Cepheid has announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert™ MRSA test, which runs on the GeneXpert® System, for the detection of ...
SUNNYVALE, Calif. , Feb. 18, 2026 /PRNewswire/ -- Cepheid today announced that it has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators ...
SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP. This ...
BioGX has previously worked with the CDC to produce a multiplex test that checks for monkeypox and orthopoxviruses using the cartridge-based GeneXpert system. Now, it is working with Cepheid to ...
US firm Cepheid is in the process of seeking approvals to manufacture point-of-care Covid-19 RT-PCR diagnostic cartridges that will be made in India. "From India's perspective, and manufacturing ...
The US Food & Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Cepheid in September 2021 for its PCRplus-based Xpert CoV-2/Flu/RSV plus multiplex test for the viruses that cause ...
Cepheid’s CPHD rapid influenza and RSV assay – the Xpert Flu+RSV Xpress test – recently won the U.S. FDA 510(k) marketing approval and the Clinical Laboratory Improvement Achievements (CLIA) waiver.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A Birmingham company is working with Cepheid to develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results